Exact Mass: 535.0567

Exact Mass Matches: 535.0567

Found 30 metabolites which its exact mass value is equals to given mass value 535.0567, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

UDP-L-Ara4N

UDP-L-Ara4N; UDP-4-amino-4-deoxy-L-arabinose; UDP-4-amino-4-deoxy-beta-L-arabinopyranose

C14H23N3O15P2 (535.0604)


A UDP-amino sugar having 4-amino-4-deoxy-beta-L-arabinopyranose as the amino sugar component.

   

Lipoyl-AMP

{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[5-(1,2-dithiolan-3-yl)pentanoyl]oxy})phosphinic acid

C18H26N5O8PS2 (535.096)


Lipoyl-amp is part of the Protein modification, and Lipoic acid metabolism pathways. It is a substrate for: Lipoyltransferase 1, mitochondrial.

   

TTF-1

3-{2-[4,5-bis(hexylsulphanyl)-2H-1,3-dithiol-2-ylidene]-5-(methylsulphanyl)-2H-1,3-dithiol-4-yl}propanenitrile

C22H33NS7 (535.0658)


   

Hydroxy dabrafenib

2,6-Difluoro-N-{2-fluoro-3-[2-(1-hydroxy-2-methylpropan-2-yl)-5-(2-imino-1,2-dihydropyrimidin-4-yl)-1,3-thiazol-4-yl]phenyl}benzene-1-sulphonamide

C23H20F3N5O3S2 (535.096)


   
   
   

2-amino-2-methylpropane-1,3-diol,(5-bromo-4-chloro-1H-indol-3-yl)phosphonic acid

2-amino-2-methylpropane-1,3-diol,(5-bromo-4-chloro-1H-indol-3-yl)phosphonic acid

C16H28BrClN3O8P (535.0486)


   
   

(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis(4-chlorophenyl)-diindeno[7,1-de:1,7-fg][1,3,2]dioxaphosphocin-5-oxide

(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis(4-chlorophenyl)-diindeno[7,1-de:1,7-fg][1,3,2]dioxaphosphocin-5-oxide

C29H22Cl2O4P (535.0633)


   

Iofolastat (123I)

Iofolastat (123I)

C19H26IN3O7 (535.0815)


C1446 - Radiopharmaceutical Compound > C2124 - Radioconjugate

   

(R)-lipoyl-AMP

(R)-lipoyl-AMP

C18H26N5O8PS2 (535.096)


A lipoyl-AMP in which the lipoyl moiety has (R)-configuration.

   

(2E)-N-[(5-bromo-2-methoxyphenyl)sulfonyl]-3-[2-(2-naphthalenylmethyl)phenyl]-2-propenamide

(2E)-N-[(5-bromo-2-methoxyphenyl)sulfonyl]-3-[2-(2-naphthalenylmethyl)phenyl]-2-propenamide

C27H22BrNO4S (535.0453)


   

Ethyl adenosine triphosphate

Ethyl adenosine triphosphate

C12H20N5O13P3 (535.027)


   

Cytidine-5-diphospho-beta-D-xylose

Cytidine-5-diphospho-beta-D-xylose

C14H23N3O15P2 (535.0604)


   

UDP-4-amino-4-deoxy-beta-L-arabinopyranose

UDP-4-amino-4-deoxy-beta-L-arabinopyranose

C14H23N3O15P2 (535.0604)


   
   
   

N-acetyldemethylphosphinothricin adenylate

N-acetyldemethylphosphinothricin adenylate

C16H21N6O11P2- (535.0744)


   

[[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S)-2,3,5-trihydroxy-4-oxopentyl] hydrogen phosphate

[[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S)-2,3,5-trihydroxy-4-oxopentyl] hydrogen phosphate

C14H23N3O15P2 (535.0604)


   

5-cytidyl-aldehydo-D-ribose

5-cytidyl-aldehydo-D-ribose

C14H23N3O15P2 (535.0604)


   

[[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3R)-2,3,5-trihydroxy-4-oxopentyl] hydrogen phosphate

[[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3R)-2,3,5-trihydroxy-4-oxopentyl] hydrogen phosphate

C14H23N3O15P2 (535.0604)


   

Lipoyl-AMP

Lipoyl-AMP

C18H26N5O8PS2 (535.096)


A purine ribonucleoside 5-monophosphate having adenine as the nucleobase and a lipoyl group attached to one of the phosphate OH groups.

   

UDP-4-amino-4-deoxy-beta-L-arabinose

UDP-4-amino-4-deoxy-beta-L-arabinose

C14H23N3O15P2 (535.0604)


   

Mito-apocynin (C2)

Mito-apocynin (C2)

C28H27BrNO3P (535.0912)


Mito-apocynin (C2), an orally active mitochondria-targeted triphenylphosphonium (TPP)-based compound, is synthesized by conjugating the Apocynin moiety with a TPP + cation. Mito-apocynin (C2) exhibits antineuroinflammatory effect[1].

   

11-chloro-1,9,10,12,15a-pentahydroxy-16-methoxy-3,14-dimethyl-7,7a-dihydro-6h-2-azahexaphene-8,15-dione

11-chloro-1,9,10,12,15a-pentahydroxy-16-methoxy-3,14-dimethyl-7,7a-dihydro-6h-2-azahexaphene-8,15-dione

C28H22ClNO8 (535.1034)


   

3,5-dimethylidene-2-oxo-4a-({[(2,2,2-trichloro-1-hydroxyethylidene)amino]carbonyl}oxy)-hexahydro-3ah-spiro[azuleno[6,5-b]furan-8,2'-oxiran]-6-yl 2-methylpropanoate

3,5-dimethylidene-2-oxo-4a-({[(2,2,2-trichloro-1-hydroxyethylidene)amino]carbonyl}oxy)-hexahydro-3ah-spiro[azuleno[6,5-b]furan-8,2'-oxiran]-6-yl 2-methylpropanoate

C22H24Cl3NO8 (535.0567)


   

22-chloro-3,5,10,28-tetrahydroxy-21-methoxy-7-methyl-14,16,19-trioxa-6-azaheptacyclo[15.11.1.0²,¹¹.0⁴,⁹.0¹³,²⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(29),2,4,6,8,10,17,20,22,24,27-undecaen-26-one

22-chloro-3,5,10,28-tetrahydroxy-21-methoxy-7-methyl-14,16,19-trioxa-6-azaheptacyclo[15.11.1.0²,¹¹.0⁴,⁹.0¹³,²⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(29),2,4,6,8,10,17,20,22,24,27-undecaen-26-one

C27H18ClNO9 (535.067)


   

(13r)-22-chloro-3,5,10,28-tetrahydroxy-21-methoxy-7-methyl-14,16,19-trioxa-6-azaheptacyclo[15.11.1.0²,¹¹.0⁴,⁹.0¹³,²⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(29),2,4,6,8,10,17,20,22,24,27-undecaen-26-one

(13r)-22-chloro-3,5,10,28-tetrahydroxy-21-methoxy-7-methyl-14,16,19-trioxa-6-azaheptacyclo[15.11.1.0²,¹¹.0⁴,⁹.0¹³,²⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(29),2,4,6,8,10,17,20,22,24,27-undecaen-26-one

C27H18ClNO9 (535.067)


   

(3ar,4as,6r,7ar,8r,9as)-3,5-dimethylidene-2-oxo-4a-({[(2,2,2-trichloro-1-hydroxyethylidene)amino]carbonyl}oxy)-hexahydro-3ah-spiro[azuleno[6,5-b]furan-8,2'-oxiran]-6-yl 2-methylpropanoate

(3ar,4as,6r,7ar,8r,9as)-3,5-dimethylidene-2-oxo-4a-({[(2,2,2-trichloro-1-hydroxyethylidene)amino]carbonyl}oxy)-hexahydro-3ah-spiro[azuleno[6,5-b]furan-8,2'-oxiran]-6-yl 2-methylpropanoate

C22H24Cl3NO8 (535.0567)